Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and lipid-derived free radicals are highly reactive, oxygen-containing molecules and lipid-based intermediates that possess unpaired electrons. They are generated as natural byproducts of mitochondrial respiration, enzymatic reactions such as those involving NADPH oxidases, and environmental exposures like radiation (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity). At physiological levels, these species function as critical signaling molecules in processes like cell proliferation, differentiation, and the immune "respiratory burst" used to kill pathogens (Sies et al., 2017, Nature Reviews Molecular Cell Biology). However, excessive accumulation leads to oxidative stress, causing irreversible damage to cellular macromolecules, including DNA mutations, protein carbonylation, and lipid peroxidation (Ayala et al., 2014, Oxidative Medicine and Cellular Longevity). This damage is a hallmark of aging and is central to the progression of neurodegenerative diseases like Alzheimer's, cardiovascular conditions like atherosclerosis, and various cancers. Pharmacological intervention typically involves radical scavengers or antioxidants that neutralize these species to prevent cellular injury, though maintaining the delicate balance of redox homeostasis remains a significant therapeutic challenge.
Direct chemical neutralization (scavenging) of unpaired electrons, reduction of reactive intermediates to stable forms, and enhancement of endogenous antioxidant enzyme systems.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and lipid-derived free radicals (ROS/LFR).